Availability |
Widespread adoption |
Limited in clinical labs |
Limited in clinical labs |
|
Application specific |
Universal use possible for bacteria/fungi |
Sent to a core facility with shared instrumentation |
|
|
Suitable for typing/molecular resistance |
Universal use for other microorganisms |
|
|
|
Expansion to typing/molecular resistance |
Procedure complexity |
Low |
High; little or no automation |
High-limited (application-specific) automation |
|
|
Lower when using a commercial kit |
Kits available for library preparation |
|
|
CLSI MM18-A2 guides analyses |
|
Accuracy |
High depending on microorganism/group being interrogated |
High if several regions covered (long reads with excellent coverage of 16S feasible |
Whole-genome sequencing provides full coverage of 16S operons |
|
Applicable to pure cultures |
Sequences must be edited and trimmed |
Application to pure cultures |
|
|
Application to pure cultures or normally sterile clinical samples with a single pathogen |
Usually less sensitive depending on assembly processes |
|
|
|
Intraoperon diversity problematic |
|
|
|
All pipelines need to be thoroughly developed for various clinical application |
|
|
|
Applicable to pure cultures |
Databases |
Ongoing development limited for various microorganisms/groups |
Covers all microorganisms/groups |
Rapidly expanding deposit of WGS data in public databases without curation |
|
Requires ongoing validation against phenotypic and sequencing results |
Several public databases are outlined in Table 2, but coverage for bacterial species of interest and reliability of annotation and sequences must be assessed |
Some freely accessible target-specific 16S databases outlined in Table 2 can be used (i.e., in packages such as Qiime, www.qiime.org), but coverage for bacterial species of interest and reliability of annotation and sequences must be assessed |
|
|
Commercial databases also available |
Whole genomes are available under the genome section of NCBI/GenBank and can be searched using BLAST |
|
|
|
Commercial databases are also available as part of an analysis package |
Cost/test |
Low, but MS instrument cost, maintenance, and database use need to be considered |
High when using a commercial kit linked to specific instruments and reagents |
High, but costs decrease when pooling samples |
|
|
|
Cost/sample is rapidly decreasing with increased throughput and read length and depends on read length |
Instrumentation |
MALDI-TOF MS instruments expensive but supplied by Becton-Dickinson (Bruker) or bioMérieux (Shimatzu) |
Requires purchase of an automated genetic analyzer |
Requires purchase of one or more NGS instruments, maintenance contracts, and reagent-rental agreements |
|
|
Capillary electrophoresis columns must be regularly maintained and replaced |
Shared core facility to minimize costs |
|
|
Separate installation to avoid contamination |
Separate installation to avoid contamination |
Quality assurance |
Laser must be regularly calibrated |
Appropriate controls must be included with each run |
Appropriate controls much be included with each run |
|
QA organisms should be regularly run to verify performance |
Appropriate controls must be used for each step of the procedure |
Appropriate controls must be included with each step of the procedure |
|
|
Sequence trimming/editing allows identification of contamination problems |
Checks on read generation, read filtering (elimination of nonspecific reads), mean read length, phred scores, concatenation/assembly efficiency must be done to ensure quality results |
Testing capacity and throughput |
Hundreds of individual isolates per day can be analyzed depending on the no. of instruments used |
Suitable for single and few samples |
Higher throughput than Sanger depending on the method and instrument being used |
|
|
No more than 8–12 isolates can be run in a day |
Pooling of samples is customary to reduce the per-sample cost |
|
|
Throughput has never been automated |
|
Data analysis |
MALDI-TOF immediately provide an answer by analysis of an isolates spectral profile against the onboard database |
Complex and general understanding of BLAST and alignments |
Complex and a major barrier to clinical implementation |
|
|
Requires sequence editing and analysis against a reference sequence |
Requires appropriate storage of large amounts of sequence data |
|
|
A multialignment against a close reference sequence should be performed |
Requires knowledge in bioinformatics and general informatics |
|
|
Reduced errors using curated commercial or online reference database |
Delayed results often taking days to complete |
|
|
Reliable results analysis using CLSI MM18-A2 guideline |
|